Cerner’s New President and CEO to Kick Off Annual Cerner Health Conference

NEXT STORY
CytoDyn to Present at Emerging Growth Conference on October 13 Followed by Live Q/A
PREV STORY
Tricol Biomedical Receives NIH Phase IIB Grant to Continue Development of its Hemostatic Device for the Prostate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis

author_avatar
NASDAQ Market News

Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13

author_avatar
NASDAQ Market News

Press news Biocartis Group NV: Disclosure of a transparency notification

author_avatar
NASDAQ Market News